NEXT
PREV

REVOLUTIONIZING THE INDUSTRY WITH COLLAMER®

Collamer is a unique lens material created and used exclusively by STAAR® Surgical Company in the Visian® ICL™, the nanoFLEX™ family of IOLs and the Afinity™ IOL.

THE WORLD’S FASTEST GROWING REFRACTIVE TECHNOLOGY

With over 400,000 lenses implanted worldwide, the Visian® ICL™ is growing at a rate faster than any other refractive technology in the world today.

STAAR TORIC IOL: THE CLEAR CHOICE FOR TORIC IOLS

An exceptional balance of stability and predictability. Predictable visual outcomes, stable design, and optical quality in everything you see.

DID YOU KNOW? A VISIAN® ICL™ IS IMPLANTED EVERY 6 MINUTES

Around the globe, the Visian ICL is becoming an increasingly popular vision correction technology. So popular, in fact, that every 6 minutes a new Visian ICL is implanted.

  • Mar 17 2014

    FDA Advisory Panel Votes in Favor of STAAR Surgical’s Visian® Toric Implantable® Collamer Lens, TICL™

    First of Kind Product in the U.S. MONROVIA, Calif., March 17, 2014 /PRNewswire/ – STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye and delivery systems reported that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. Food and Drug Administration’s (FDA) Ophthalmic Devices Panel of the Medical […]

  • Mar 3 2014

    Visian ICL With Centraflow Approved to Market in Japan

    Over 50,000 ICLs Successfully Implanted with CentraFLOW Driven by the KS-AquaPORT Technology™   MONROVIA, Calif., March 3, 2014 /PRNewswire/ – STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that its Visian Implantable Collamer Lens with CentraFLOW technology, which is driven by the KS-AquaPORT, has been approved by the Japanese Ministry […]

  • Feb 26 2014

    Staar Surgical Reports 15% Fourth Quarter Revenue Growth and 13% Full Year 2013

    ~Total Sales Increased 22% in Constant Currency from Q4 2012 ~~ Record Quarterly Visian® ICL™ Sales Increased to $11.5 Million ~~ICL Revenue Up 34% in APAC, 27% in EMEA Regions and 36% in North America ~~Total IOL Sales Decreased 2%; Increased 12% in Constant Currency ~~FDA’s Ophthalmic Devices Panel on Visian TICL Rescheduled for March […]

  • Staar MD

    PHYSICIAN RESOURCES

    STAAR MD

    Welcome to STAARMD.com, a surgeon’s source for the latest materials from STAAR® products. From the Visian ICL® to the STAAR Toric IOL, this site contains information, resources, and materials geared toward supporting practice development.

  • 1363736701img02

    CONSUMER RESOURCES

    VISIAN ICL

    Welcome to VISIANINFO.com, a consumer’s source for the latest information about STAAR’s revolutionary product, the Visian Implantable Collamer® Lens. From product information to patient testimonials, this site contains information, resources and materials geared toward helping prospective consumers learn more about the Visian ICL.